JGP Global Gestao de Recursos Ltda. Purchases 102 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

JGP Global Gestao de Recursos Ltda. boosted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMOGet Rating) by 5.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,849 shares of the medical research company’s stock after purchasing an additional 102 shares during the period. Thermo Fisher Scientific comprises 0.8% of JGP Global Gestao de Recursos Ltda.’s holdings, making the stock its 12th largest position. JGP Global Gestao de Recursos Ltda.’s holdings in Thermo Fisher Scientific were worth $938,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the company. Opal Wealth Advisors LLC raised its holdings in shares of Thermo Fisher Scientific by 2.7% during the second quarter. Opal Wealth Advisors LLC now owns 643 shares of the medical research company’s stock valued at $349,000 after purchasing an additional 17 shares during the period. Fortitude Advisory Group L.L.C. raised its holdings in shares of Thermo Fisher Scientific by 1.8% during the second quarter. Fortitude Advisory Group L.L.C. now owns 987 shares of the medical research company’s stock valued at $536,000 after purchasing an additional 17 shares during the period. Creative Financial Designs Inc. ADV raised its holdings in shares of Thermo Fisher Scientific by 11.9% during the second quarter. Creative Financial Designs Inc. ADV now owns 169 shares of the medical research company’s stock valued at $92,000 after purchasing an additional 18 shares during the period. Tradition Wealth Management LLC raised its holdings in shares of Thermo Fisher Scientific by 2.2% during the second quarter. Tradition Wealth Management LLC now owns 837 shares of the medical research company’s stock valued at $455,000 after purchasing an additional 18 shares during the period. Finally, Hemington Wealth Management raised its holdings in shares of Thermo Fisher Scientific by 3.9% during the second quarter. Hemington Wealth Management now owns 506 shares of the medical research company’s stock valued at $275,000 after purchasing an additional 19 shares during the period. Institutional investors own 85.92% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. SVB Leerink upped their price objective on shares of Thermo Fisher Scientific from $555.00 to $620.00 and gave the company an “outperform” rating in a report on Friday, January 6th. Benchmark downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Thursday, October 27th. Credit Suisse Group decreased their target price on shares of Thermo Fisher Scientific to $620.00 in a research report on Thursday, October 27th. Royal Bank of Canada began coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, December 6th. They set an “outperform” rating and a $661.00 target price for the company. Finally, StockNews.com began coverage on shares of Thermo Fisher Scientific in a research report on Wednesday, October 12th. They set a “buy” rating for the company. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $633.30.

Thermo Fisher Scientific Trading Down 4.0 %

Shares of TMO stock opened at $580.72 on Wednesday. Thermo Fisher Scientific Inc. has a 52-week low of $475.77 and a 52-week high of $618.35. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.22 and a current ratio of 1.74. The company has a 50-day simple moving average of $556.73 and a two-hundred day simple moving average of $547.95. The company has a market capitalization of $227.76 billion, a price-to-earnings ratio of 32.64, a PEG ratio of 2.11 and a beta of 0.83.

Thermo Fisher Scientific (NYSE:TMOGet Rating) last issued its quarterly earnings data on Wednesday, October 26th. The medical research company reported $5.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.78 by $0.30. Thermo Fisher Scientific had a net margin of 15.92% and a return on equity of 22.97%. The business had revenue of $10.68 billion during the quarter, compared to the consensus estimate of $9.86 billion. Research analysts anticipate that Thermo Fisher Scientific Inc. will post 23.04 EPS for the current fiscal year.

Thermo Fisher Scientific Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, January 16th. Stockholders of record on Thursday, December 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.21%. The ex-dividend date of this dividend was Wednesday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 6.75%.

Thermo Fisher Scientific announced that its Board of Directors has approved a share buyback plan on Thursday, November 10th that allows the company to buyback $4.00 billion in outstanding shares. This buyback authorization allows the medical research company to purchase up to 2% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.

Insider Activity

In other news, EVP Gianluca Pettiti sold 4,975 shares of the stock in a transaction that occurred on Tuesday, December 13th. The shares were sold at an average price of $576.84, for a total transaction of $2,869,779.00. Following the completion of the transaction, the executive vice president now directly owns 16,450 shares of the company’s stock, valued at approximately $9,489,018. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Gianluca Pettiti sold 4,975 shares of the stock in a transaction that occurred on Tuesday, December 13th. The shares were sold at an average price of $576.84, for a total transaction of $2,869,779.00. Following the completion of the transaction, the executive vice president now directly owns 16,450 shares of the company’s stock, valued at approximately $9,489,018. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Marc N. Casper sold 10,000 shares of the stock in a transaction that occurred on Monday, October 31st. The shares were sold at an average price of $509.97, for a total transaction of $5,099,700.00. Following the transaction, the chief executive officer now directly owns 178,005 shares of the company’s stock, valued at $90,777,209.85. The disclosure for this sale can be found here. Insiders sold 31,475 shares of company stock valued at $16,073,443 in the last three months. Company insiders own 0.43% of the company’s stock.

Thermo Fisher Scientific Company Profile

(Get Rating)

Thermo Fisher Scientific, Inc engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

See Also

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMOGet Rating).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.